![Brett Fleshman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brett Fleshman
Director/Board Member at NovaQuest Capital Management LLC
Profile
Brett Fleshman is a professional who currently works as a Managing Director at NovaQuest Capital Management LLC since 2020.
Prior to this, he worked as a Vice President at Veloxis Pharmaceuticals, Inc. from 2016 to 2020.
Mr. Fleshman completed his undergraduate degree from Olin Business School in 1999.
Brett Fleshman active positions
Companies | Position | Start |
---|---|---|
NovaQuest Capital Management LLC
![]() NovaQuest Capital Management LLC Investment ManagersFinance NovaQuest Capital Management LLC (NovaQuest Capital Management) is a private equity firm founded in 2010 by John Layton Bradley and Jonathan Edward Tunnicliffe. The firm is headquartered in Raleigh, North Carolina. | Director/Board Member | 2020-07-31 |
Former positions of Brett Fleshman
Companies | Position | End |
---|---|---|
Veloxis Pharmaceuticals, Inc.
![]() Veloxis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Asahi Kasei Corp., Veloxis Pharmaceuticals, Inc. manufactures pharmaceuticals for kidney transplant patients. The company is based in Edison, NJ. | Private Equity Investor | 2020-07-31 |
Training of Brett Fleshman
Olin Business School | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
NovaQuest Capital Management LLC
![]() NovaQuest Capital Management LLC Investment ManagersFinance NovaQuest Capital Management LLC (NovaQuest Capital Management) is a private equity firm founded in 2010 by John Layton Bradley and Jonathan Edward Tunnicliffe. The firm is headquartered in Raleigh, North Carolina. | Finance |
Veloxis Pharmaceuticals, Inc.
![]() Veloxis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Asahi Kasei Corp., Veloxis Pharmaceuticals, Inc. manufactures pharmaceuticals for kidney transplant patients. The company is based in Edison, NJ. | Health Technology |
- Stock Market
- Insiders
- Brett Fleshman